Illumine Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Illumine Investment Management's LLY Position: Q1 2026 in Review
Illumine Investment Management increased its Eli Lilly (LLY) stake by 3.4% in Q1 2026, buying an estimated $20.3K and bringing the position to 600 shares worth $552K. The position accounts for 0.42% of the portfolio, ranked #73.
Illumine Investment Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $623K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Illumine Investment Management held 600 shares of Eli Lilly worth $552K as of Q1 2026.
- Illumine Investment Management bought 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
- Eli Lilly made up 0.42% of Illumine Investment Management's portfolio in Q1 2026, its #73 holding.
- Illumine Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Illumine Investment Management's Eli Lilly position peaked at $623K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Illumine Investment Management's 13F filing for Q1 2026, filed 4 May 2026.